Market Closed -
Hong Kong S.E.
01:38:42 28/06/2024 pm IST
|
5-day change
|
1st Jan Change
|
7.97
HKD
|
+3.64%
|
|
+17.90%
|
-29.34%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,947
|
4,755
|
3,213
|
2,325
|
-
|
-
|
Enterprise Value (EV)
1 |
1,834
|
3,816
|
2,809
|
1,871
|
1,806
|
1,648
|
P/E ratio
|
-
|
66
x
|
205
x
|
26.5
x
|
18.5
x
|
14.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
9.7
x
|
12
x
|
6.78
x
|
4.1
x
|
3.33
x
|
2.71
x
|
EV / Revenue
|
6.04
x
|
9.65
x
|
5.93
x
|
3.3
x
|
2.59
x
|
1.92
x
|
EV / EBITDA
|
55.7
x
|
41.7
x
|
53.7
x
|
17.2
x
|
11.4
x
|
8.32
x
|
EV / FCF
|
-
|
-3,40,24,860
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-0%
|
-
|
-
|
-
|
-
|
Price to Book
|
2.44
x
|
3.73
x
|
2.38
x
|
1.62
x
|
1.49
x
|
1.35
x
|
Nbr of stocks (in thousands)
|
3,13,389
|
3,13,389
|
3,13,389
|
3,13,389
|
-
|
-
|
Reference price
2 |
9.403
|
15.17
|
10.25
|
7.417
|
7.417
|
7.417
|
Announcement Date
|
29/03/22
|
23/03/23
|
25/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
303.8
|
395.5
|
473.8
|
567.4
|
698.6
|
857.5
|
EBITDA
1 |
32.92
|
91.52
|
52.28
|
108.9
|
158.2
|
198.1
|
EBIT
1 |
20.52
|
72.08
|
25.01
|
76.6
|
125.7
|
165.5
|
Operating Margin
|
6.75%
|
18.22%
|
5.28%
|
13.5%
|
18%
|
19.3%
|
Earnings before Tax (EBT)
1 |
-
|
70.32
|
14.45
|
86.71
|
137.1
|
177.8
|
Net income
1 |
-
|
70.14
|
14.49
|
84.98
|
120.7
|
151.2
|
Net margin
|
-
|
17.73%
|
3.06%
|
14.98%
|
17.27%
|
17.63%
|
EPS
2 |
-
|
0.2300
|
0.0500
|
0.2800
|
0.4000
|
0.5000
|
Free Cash Flow
|
-
|
-112.2
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-28.36%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
29/03/22
|
23/03/23
|
25/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1,113
|
939
|
404
|
453
|
518
|
677
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-112
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-17.1%
|
5.65%
|
1.13%
|
6.35%
|
8.37%
|
9.58%
|
ROA (Net income/ Total Assets)
|
-
|
5.16%
|
0.96%
|
-
|
-
|
-
|
Assets
1 |
-
|
1,359
|
1,511
|
-
|
-
|
-
|
Book Value Per Share
2 |
3.850
|
4.070
|
4.310
|
4.590
|
4.990
|
5.490
|
Cash Flow per Share
|
-
|
-0.2300
|
-0.0400
|
-
|
-
|
-
|
Capex
|
-
|
43.4
|
79.6
|
-
|
-
|
-
|
Capex / Sales
|
-
|
10.97%
|
16.8%
|
-
|
-
|
-
|
Announcement Date
|
29/03/22
|
23/03/23
|
25/03/24
|
-
|
-
|
-
|
Last Close Price
7.417
CNY Average target price
9.773
CNY Spread / Average Target +31.76% Consensus |
1st Jan change
|
Capi.
|
---|
| -29.34% | 320M | | +75.69% | 12.57B | | -29.60% | 6.98B | | -0.69% | 6.69B | | +9.17% | 5.18B | | +15.44% | 4.18B | | -23.98% | 3.81B | | -22.69% | 2.8B | | -1.49% | 2B | | +16.21% | 1.84B |
Medical Equipment
|